Based on these findings, we hypothesize that MSH6/2 and PD-L1 expressions could affect pituitary tumor proliferation, and invasion by pathological classification of NFPAs and ICIs may be effective for NFPA subtypes with decreased MSH6/2 expression and increased PD-L1 expression. Here, CD274 is linked to pituitary tumor.